Related Experiment Video
Updated: May 31, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
Microencapsulation enhances the anti-ulcerogenic properties of Entada africana leaf extract
1Department of Pharmacology and Toxicology, National Institute for Pharmaceutical Research and Development, Idu, P.M.B.21 Garki, Abuja, Nigeria.
Ethnopharmacological Relevance:
The antiulcer potentials of most plants still remain largely unexplored, despite their prospects evidenced by their use as ethnomedicine. Entada africana (Mimosaceae) has been widely used in Africa for the treatment of skin infections, wounds, tonic for stomach troubles and against diphtheria-like throat complaints. The aim of the present study was to evaluate the anti-ulcer properties of Entada africana (EA) ethanol leaf extract and to obtain a novel multiparticulate pharmaceutical formulation (ACE) with it.
Materials And Methods:
Ethanol or Indomethacin was administered to rats after oral administration of EA (200, 400 and 800 mg extract/kg b.w), ACE (400 and 800 mg/kg bw), cimetidine (100mg/kg bw), misoprostol (40 μg/kg bw) or distilled water/saline (vehicle). Anti ulcer property was evaluated by examining and scoring stomach lesions.
Results:
The extract exhibited significant (P<0.01) cytoprotective effect against ethanol and indomethacin induced gastro ulceration. The microcapsules showed enhanced cytoprotective effect against ethanol and indomethacin induced gastro ulceration. Histopathologically, the effects of EA and ACE on mucus epithelia were mild with reduced neutrophil, eosinophil and lymphocytic infiltration in stomach tissues of rats ulcerated with ethanol.
Conclusions:
Our current findings show that EA and its multiparticulate formulation may be a useful preparation in peptic ulcer disease.
Related Concept Videos
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Drugs for Treatment of Ulcerative Colitis in IBD
Bioavailability Enhancement: Drug Permeability Enhancement
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
